v3.26.1
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Sep. 30, 2023
Sep. 27, 2025
Mar. 28, 2026
Mar. 29, 2025
Mar. 30, 2024
Intangible Asset, Finite-Lived [Line Items]              
Purchase accounting adjustments           $ (19,248,000)  
Divestitures           6,381,000  
Reporting unit, percentage of fair value in excess of carrying amount 6.00%       6.00%    
Fair value measurement, input measurement, discount rate         10.50%    
Intangible asset, including goodwill, impairment loss     $ 10,400,000        
Impairment of intangible assets         $ 86,546,000 2,391,000 $ 10,419,000
Intangible asset, finite-lived, after accumulated amortization $ 441,752,000 $ 446,553,000     441,752,000 446,553,000  
Gross Carrying Amount 805,515,000 762,866,000     805,515,000 762,866,000  
Amortization of acquired intangible assets         50,500,000 55,600,000 41,400,000
Software development costs capitalized         6,700,000 7,700,000  
Software costs capitalized, net 101,800,000 94,700,000     101,800,000 94,700,000  
Non-amortizable intangibles 5,903,000 9,190,000     5,903,000 9,190,000  
Capitalized costs amortized (placed into service)         6,100,000 6,700,000 $ 8,600,000
Reporting unit, carrying value 821,600,000       821,600,000    
In-process software development              
Intangible Asset, Finite-Lived [Line Items]              
Non-amortizable intangibles $ 5,900,000 $ 9,200,000     $ 5,900,000 $ 9,200,000  
Minimum              
Intangible Asset, Finite-Lived [Line Items]              
Weighted average useful life 5 years       5 years    
Maximum              
Intangible Asset, Finite-Lived [Line Items]              
Weighted average useful life 15 years       15 years    
Attune Medical              
Intangible Asset, Finite-Lived [Line Items]              
Fair value measurement, input measurement, discount rate         19.80%    
Impairment of intangible assets $ 77,200,000            
Finite-lived intangible assets, fair value disclosure 11,300,000       $ 11,300,000    
Intellectual Property              
Intangible Asset, Finite-Lived [Line Items]              
Impairment of intangible assets       $ 9,300,000      
Finite-lived intangible assets, fair value disclosure $ 800,000       $ 800,000    
Weighted average useful life 5 years       5 years    
Developed technology              
Intangible Asset, Finite-Lived [Line Items]              
Weighted average useful life 11 years 7 months 6 days 12 years 1 month 6 days     11 years 7 months 6 days 12 years 1 month 6 days  
Intangible asset, finite-lived, after accumulated amortization $ 363,517,000 $ 350,021,000     $ 363,517,000 $ 350,021,000  
Gross Carrying Amount 556,631,000 506,144,000     556,631,000 506,144,000  
Developed technology | Vivasure Medical LTD              
Intangible Asset, Finite-Lived [Line Items]              
Intangible asset, finite-lived, after accumulated amortization 117,100,000       117,100,000    
Revision of Prior Period, Reclassification, Adjustment              
Intangible Asset, Finite-Lived [Line Items]              
Divestitures   $ 6,400,000          
Hospital              
Intangible Asset, Finite-Lived [Line Items]              
Purchase accounting adjustments           (19,248,000)  
Divestitures           0  
Reporting unit, fair value 867,800,000       867,800,000    
Blood Center              
Intangible Asset, Finite-Lived [Line Items]              
Purchase accounting adjustments           0  
Divestitures           $ 6,381,000  
Intangible asset, finite-lived, after accumulated amortization 0       0    
Gross Carrying Amount $ 185,600,000       $ 185,600,000